Bobak R. Azamian
Director, President/CEO and Board Chair · 4 filings · Latest: Jun 17, 2026
Tarsus Pharmaceuticals, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
TARS | Bobak R. Azamian | Director, President/CEO and Board Chair | Jun 17, 2026 | Sale | $61.55 | 10,000 | $615.5K | 847,991 | |
TARS | BOBAK AZAMIAN | — | Jun 17, 2026 | Proposed Sale | $61.55 | 10,000 | $615.5K | — | |
TARS | Bobak R. Azamian | Director, President/CEO and Board Chair | Mar 19, 2026 | Sale | $67.00 | 11,964 | $801.6K | 33,421 | |
TARS | Bobak R. Azamian | Director, President/CEO and Board Chair | Mar 18, 2026 | Sale | $68.71 | 11,667 | $801.6K | 45,385 | |
TARS | Bobak R. Azamian | Director, President/CEO and Board Chair | Mar 17, 2026 | Sale | $69.42 | 10,972 | $761.7K | 57,052 | |
TARS | Azamian Bobak R. | — | Mar 19, 2026 | Proposed Sale | $67.00 | 11,964 | $801.6K | — | |
TARS | Azamian Bobak R. | — | Mar 18, 2026 | Proposed Sale | $68.71 | 11,667 | $801.6K | — | |
TARS | Bobak R. Azamian | Director, President/CEO and Board Chair | Mar 15, 2026 | Option Exercise | — | 66,274 | — | 68,024 | |
TARS | Azamian Bobak R. | — | Mar 17, 2026 | Proposed Sale | $69.41 | 10,972 | $761.6K | — | |
TARS | WILLIAM J LINK | — | Mar 16, 2026 | Proposed Sale | $68.78 | 12,500 | $859.8K | — | |
TARS | BOBAK AZAMIAN | — | Dec 24, 2025 | Proposed Sale | $82.51 | 6,000 | $495.1K | — | |
TARS | Bobak Azamian Living Trust | — | Sep 24, 2025 | Proposed Sale | $55.37 | 6,000 | $332.2K | — | |
TARS | Azamian Bobak R. | — | Aug 11, 2025 | Proposed Sale | $50.00 | 6,000 | $300.0K | — | |
TARS | Azamian Bobak R. | — | Mar 24, 2025 | Proposed Sale | $50.00 | 6,000 | $300.0K | — | |
TARS | Azamian Bobak R. | — | Mar 20, 2025 | Proposed Sale | $50.11 | 8,534 | $427.7K | — | |
TARS | Azamian Bobak R. | — | Mar 19, 2025 | Proposed Sale | $47.40 | 8,551 | $405.3K | — | |
TARS | Azamian Bobak R. | — | Mar 18, 2025 | Proposed Sale | $46.28 | 7,131 | $330.1K | — |